Legend Biotech (NASDAQ: LEGN) reported Q2 EPS of ($0.57), $0.21 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $73.33 million versus the consensus estimate of $54.56 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.